Basically yes, take a look at the not for human consumption drug, sorry medicine market.

Was analogs in the 2010s, Obama had to pass the analog act low… now it’s back with peptides and glp 1 which aren’t scheduled but..

Yeah I guess make enough money and then lobby for the benefit of your audience base or for future proscuation